Blockchain Registration Transaction Record

GeoVax Unveils Breakthrough COVID-19 Vaccine Data at Keystone Symposia

GeoVax Labs presents data on GEO-CM04S1 vaccine's efficacy against COVID-19 variants at Keystone Symposia, showcasing potential for broader immunity.

GeoVax Unveils Breakthrough COVID-19 Vaccine Data at Keystone Symposia

This news is crucial as it highlights advancements in vaccine technology that could offer broader protection against COVID-19 and its variants, especially for immunocompromised individuals who may not respond well to current vaccines. The development of such vaccines is a significant step forward in the global fight against the pandemic, ensuring more comprehensive and durable immunity for diverse populations.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x6eb568bcf041521ea6b996d59b0c3148314a4245192c90fc5541d7fee272e208
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintdavebqZD-0cd9a1446d134c230f2461b0c85a05b9